about
The role of the substantia nigra pars compacta in regulating sleep patterns in ratsReview of the therapeutic management of Parkinson's disease. Report of a joint task force of the European Federation of Neurological Societies and the Movement Disorder Society-European Section. Part I: early (uncomplicated) Parkinson's disease.Multi-organ distribution of phosphorylated alpha-synuclein histopathology in subjects with Lewy body disorders.Prevalence of Submandibular Gland Synucleinopathy in Parkinson's Disease, Dementia with Lewy Bodies and other Lewy Body DisordersThe spectrum of cognitive impairment in Lewy body diseasesTherapeutic effects of melatonin receptor agonists on sleep and comorbid disorders.Clinical aspects of palliative care in advanced Parkinson's disease.Current status and future directions of gene expression profiling in Parkinson's disease.Therapeutic potential of melatonin and its analogs in Parkinson's disease: focus on sleep and neuroprotection.Bilateral transplantation of allogenic adult human bone marrow-derived mesenchymal stem cells into the subventricular zone of Parkinson's disease: a pilot clinical study.Metacognitive Performance, the Tip-of-Tongue Experience, Is Not Disrupted in Parkinsonian Patients.Endurance exercise promotes cardiorespiratory rehabilitation without neurorestoration in the chronic mouse model of parkinsonism with severe neurodegeneration.Community-based Argentine tango dance program is associated with increased activity participation among individuals with Parkinson's disease.The patient with Parkinson's disease: part I-treating the motor symptoms; part II-treating the nonmotor symptoms.Autonomic function, as self-reported on the SCOPA-autonomic questionnaire, is normal in essential tremor but not in Parkinson's diseaseOlfactory bulb alpha-synucleinopathy has high specificity and sensitivity for Lewy body disorders.Treatment options for non-motor symptoms in late-stage Parkinson's disease.The Effects of Dietary Fat and Iron Interaction on Brain Regional Iron Contents and Stereotypical Behaviors in Male C57BL/6J Mice.New insights into the pathology of Parkinson's disease: does the peripheral autonomic system become central?Bone marrow-derived mesenchymal stem cell therapy as a candidate disease-modifying strategy in Parkinson's disease and multiple system atrophy.Protocol for a randomised controlled trial: efficacy of donepezil against psychosis in Parkinson's disease (EDAP)Reduced striatal tyrosine hydroxylase in incidental Lewy body disease.Unified staging system for Lewy body disorders: correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunction.Scales for assessing nonmotor symptom severity changes in Parkinson's disease patients with symptom fluctuations.Summary of the recommendations of the EFNS/MDS-ES review on therapeutic management of Parkinson's disease.The cerebellum in Parkinson's disease.Sall3 correlates with the expression of TH in mouse olfactory bulb.Unchanged gastric emptying and visceral perception in early Parkinson's disease after a high caloric test meal.Psychometric validation of the revised SCOPA-Diary Card: expanding the measurement of non-motor symptoms in Parkinson's disease.Self-Reported Symptoms of Parkinson's Disease by Sex and Disease Duration.Impulse control behaviors and subthalamic deep brain stimulation in Parkinson disease.Mild cognitive impairment in Parkinson's disease: a distinct clinical entity?Wisconsin Card Sorting Test in Parkinson's disease: diffusion tensor imaging.Risk of incident depression in patients with Parkinson disease in the UK.Effects of Agmatine on Depressive-Like Behavior Induced by Intracerebroventricular Administration of 1-Methyl-4-phenylpyridinium (MPP(+)).Influence of deep brain stimulation and levodopa on sensory signs in Parkinson's disease.Alpha-synuclein pathology of the spinal and peripheral autonomic nervous system in neurologically unimpaired elderly subjects.Cutaneous autonomic denervation in Parkinson's disease.Early (Uncomplicated) Parkinson's Disease
P2860
Q21562323-2A1F45ED-8CBA-4707-A5C6-16BCC7AFF76DQ33260250-6C5EF50A-669E-4C6B-87CA-514C1F86A2B8Q33835599-F574FD43-B436-4A15-8B97-A9BFFFEC45BCQ33874572-A5D1C694-A3E8-43A5-9D98-5FE2A601F2BCQ34019751-DD4F72EE-A179-4E93-8504-CF25891302E0Q34358480-F3C0AF1D-4A33-437C-B66D-85A62AE6B667Q34457767-D9F9BB46-7F2E-44AF-A24E-824C943A0CD4Q34612367-129EFF9C-B840-453C-9690-0883A14C8574Q35276597-D7C30346-2D56-495E-BC00-BAD528E8F4C2Q35893878-E831CDC7-7409-4ABB-B8F8-5E50B2577A0BQ35944936-C8235925-B098-4595-B482-9B3B67737599Q36177056-D7662806-480B-4BE3-8B77-A161B9032555Q36569450-4D3DFBBB-0D2F-41CA-9561-4A9414063BC3Q36790054-609F3147-B603-4A7A-944F-5256B1024AD5Q36880750-E8F3AFF6-4BC6-4B22-9E86-C572314B91CAQ37073141-D263DF33-6658-4FFC-B81F-9CF08F77242BQ37098986-7BB6B949-480B-4321-AC7B-1735F4BAF05AQ37112422-75677579-9B95-4C8E-9403-80E6284A5432Q37114109-FAA560F0-565B-4159-9C9C-FF9A58CC2468Q37203372-CE73A129-6435-4625-9BC0-8B6F902BB495Q37208415-BB48ED3D-F035-4EBD-B4AC-14EC8963934FQ37299447-4E2E63EB-488B-4383-85D3-0BA1B032249AQ37376010-53A85A48-7387-44D2-8031-BD8E5FF7BC0AQ37771022-FD593F1D-1478-436D-8558-0682CCDE3BE9Q38070888-3507FC76-4C3F-48A3-8C5E-379238765BDAQ38081095-B4864E2C-D91A-4038-BDEA-8631DD87D873Q38333989-F8C02C83-BB53-4900-97FB-F3A3B2135ABFQ38410342-453B236D-7888-455D-A407-A7A8654899D2Q38424277-4435C329-195F-4259-82B3-F6BF614B8E63Q38818116-92564A40-B319-4BDB-BB0F-1AD39281BA14Q40530060-3C3E0A23-6CE6-49A1-92BB-76724EB4EFE6Q41152157-0CEC775E-E049-47A4-B801-082F47036794Q42516643-62FDDF3A-D711-49CC-96E8-AAB75BFCDB48Q44696944-ECA158A6-A661-44EB-8BA5-968EA2776FE6Q48078497-8B71F6D9-2077-4C83-B81C-6BBD2F952EA1Q48128647-84DC7C53-B5A5-4C34-8D6E-E11059506EFCQ48566508-2D6850A5-5385-46A3-9059-35CFA31DC967Q50454539-73B148B8-CE87-4FC5-BCFE-98BC5942E14FQ58870319-2BD20640-8C31-47C0-8E7B-33F578F2452A
P2860
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Nonmotor complications in Parkinson's disease.
@ast
Nonmotor complications in Parkinson's disease.
@en
Nonmotor complications in Parkinson's disease.
@nl
type
label
Nonmotor complications in Parkinson's disease.
@ast
Nonmotor complications in Parkinson's disease.
@en
Nonmotor complications in Parkinson's disease.
@nl
prefLabel
Nonmotor complications in Parkinson's disease.
@ast
Nonmotor complications in Parkinson's disease.
@en
Nonmotor complications in Parkinson's disease.
@nl
P2860
P356
P1433
P1476
Nonmotor complications in Parkinson's disease.
@en
P2860
P356
10.1002/MDS.20460
P407
P478
20 Suppl 11
P577
2005-01-01T00:00:00Z